By Jenny Ruth
|
Monday 31st May 2010 |
Text too small? |

Tower Australia net earnings in the six months ended March, which were up 5% to $A28.4 million ($NZ35.4 million), suffered from an increase in life claim costs, says David Ellis, an analyst at Aegis Equities Research in Sydney.
"The first-half earnings result was below our expectations and we have reduced our full-year 2010 and 2011 targets to take into account the slower start to the year," Ellis says.
"We retain positive medium term earnings growth assumptions on the back of solid industry dynamics, improved sales performance, particularly in group risk, a recovery in investment markets, better claims experience and reduced unit costs."
Ellis says he is positive on the longer-term outlook for Tower due to its strengthening market position, well-balanced product and distribution platform, tight expense control and strong capital position.
Tower plans to raise $A96 million from a fully underwritten one-for-seven renounceable rights issued priced at $A1.85 a share ($NZ2.29 for New Zealand shareholders), a 20% discount to the theoretical ex-rights price.
Ellis says the capital raising is a surprise, "particularly as the life insurer maintains the
additional capital will be used for future unidentified growth opportunities." Even before the capital raising, its solvency levels are well above regulatory minimums.
Recommendation: buy.
No comments yet
STU - Steel & Tube - Trading Update and Facility Extension
ARG - Argosy FY27 Interim Result
RGI - Reefton Resource Update and PFS
NPH - 2026 Full Year Results
Devon Funds Morning Note - 18 November 2026
IFT - Interim results for the period ended 30 September 2026
November 18th Morning Report
IPL - Interim Results HY27
SEK - Seeka Announces Launch of 2026 Grower Loyalty Share Scheme
SAN - Sanford delivers a record profit for FY26